Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19

The outbreak of severe acute respiratory syndrome coronavirus-2 is causing a serious disaster through coronavirus disease-19 (COVID-19) around the globe. A large segment of the population from every corner of the world is already infected with this dreadful pathogen with a high mortality rate. These...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Rashi, Mujwar, Somdutt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418093/
https://www.ncbi.nlm.nih.gov/pubmed/32837119
http://dx.doi.org/10.1007/s11224-020-01605-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418093/
https://www.ncbi.nlm.nih.gov/pubmed/32837119
http://dx.doi.org/10.1007/s11224-020-01605-w

Ejemplares similares